HTLV-1 Antigenicity Data for mRNA Vaccine Design

5.5 KB of data on the antigenicity of Human T-lymphotropic virus type 1 (HTLV-1) proteins, used in an AI-driven reverse vaccinology study. The dataset, authored by Nadia Seifi and last updated in May 2026, contains results from immunoinformatics tools analyzing the two most antigenic viral proteins to identify T- and B-cell epitopes for a candidate mRNA vaccine.

Use Cases

• Training epitope prediction models based on identified antigenic immunodominant epitopes.
• Evaluating vaccine candidate structures based on modeled 3D structures and docking analyses.
• Comparing immunological and physicochemical properties of proposed vaccine constructs.

Strengths

• Dataset is focused on a specific, high-impact research goal: designing an mRNA vaccine against HTLV-1.
• Results are derived from multiple immunoinformatics tools, suggesting a multi-method computational approach.
• Data is openly shared under a CC-BY-4.0 license, facilitating reuse and verification.

Limitations

• Row count is unknown, which may limit suitability assessment for machine learning.
• Column-level documentation is absent; field semantics must be inferred after download.
• The description notes that additional experimental studies are required to confirm the vaccine's efficacy.

Provenance

Source

Nadia Seifi via figshare

Collection Method

Computational analysis using an artificial intelligence-driven reverse vaccinology approach and multiple immunoinformatics tools.

Time Range

null

Freshness

Last updated 2026-05-06 17:32:00; freshness should be verified.

Geography

null